Astrocyte CD38-erk Mapk signaling controls mitochondrial transfer to neurons via Tnt-mediated vesicle trafficking

Target: CD38 Composite Score: 0.000 Price: $0.50 Citation Quality: Pending ALS and Alzheimer's disease Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
5
Citations
1
Debates
5
Supporting
0
Opposing
Quality Report Card click to collapse
F
Composite: 0.000
Top 50% of 1512 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
F Mech. Plausibility 15% 0.00 Top 50%
B+ Evidence Strength 15% 0.72 Top 19%
B Novelty 12% 0.68 Top 54%
B+ Feasibility 12% 0.78 Top 25%
F Impact 12% 0.00 Top 50%
F Druggability 10% 0.00 Top 50%
F Safety Profile 8% 0.00 Top 50%
F Competition 6% 0.00 Top 50%
F Data Availability 5% 0.00 Top 50%
F Reproducibility 5% 0.00 Top 50%
Evidence
5 supporting | 0 opposing
Citation quality: 0%
Debates
2 sessions B+
Avg quality: 0.76
Convergence
0.00 F 1 related hypotheses share this target

From Analysis:

Mitochondrial transfer between neurons and glia

Mitochondrial transfer between neurons and glia?

→ View full analysis & debate transcript

Description

Under neurodegenerative stress, astrocytes upregulate CD38, which triggers Erk MAPK signaling to promote tunneling nanotube (TNT) formation through M-Sec (TNFAIP2) and F-actin remodeling, enabling astrocyte-to-neuron mitochondrial transfer. These transferred mitochondria exhibit enhanced membrane potential and ATP production, restoring neuronal bioenergetics and reducing apoptosis. Disruption of astrocyte CD38 signaling (via CD38 knockout or Erk inhibition) impairs TNT formation and mitochondrial transfer, leading to accelerated neuronal loss in ALS/AD models. This predicts that pharmacologic CD38 agonism or direct administration of astrocyte-derived mitochondria will ameliorate motor/cognitive deficits in rodent neurodegeneration models.

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.00 (15%) Evidence 0.72 (15%) Novelty 0.68 (12%) Feasibility 0.78 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.000 composite
5 citations 5 with PMID 5 medium Validation: 0% 5 supporting / 0 opposing
For (5)
5
No opposing evidence
(0) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
2
3
MECH 2CLIN 0GENE 3EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
Transfer of mitochondria from astrocytes to neuron…SupportingGENENature MEDIUM2016-PMID:27466127-
Ginsenoside Rb1 inhibits astrocyte activation and …SupportingMECHRedox Biol MEDIUM2022-PMID:35696763-
Spatial transcriptomics reveal neuron-astrocyte sy…SupportingGENENature MEDIUM2024-PMID:38326616-
CD38 in Neurodegeneration and Neuroinflammation.SupportingGENECells MEDIUM2020-PMID:32085567-
Aerobic Exercise Improves Cognitive Recovery in Mi…SupportingMECHAging Dis MEDIUM2024-PMID:39751866-
Legacy Card View — expandable citation cards

Supporting Evidence 5

Transfer of mitochondria from astrocytes to neurons after stroke. MEDIUM
Nature · 2016 · PMID:27466127
Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons agai… MEDIUM
Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke.
Redox Biol · 2022 · PMID:35696763
Spatial transcriptomics reveal neuron-astrocyte synergy in long-term memory. MEDIUM
Nature · 2024 · PMID:38326616
CD38 in Neurodegeneration and Neuroinflammation. MEDIUM
Cells · 2020 · PMID:32085567
Aerobic Exercise Improves Cognitive Recovery in Mice with Chronic Cerebral Hypoperfusion by Modulating the Ann… MEDIUM
Aerobic Exercise Improves Cognitive Recovery in Mice with Chronic Cerebral Hypoperfusion by Modulating the Annexin-A1-MAPK Axis and Astrocyte Polarization.
Aging Dis · 2024 · PMID:39751866

Opposing Evidence 0

No evidence recorded
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-12 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Novel Mechanistic Hypotheses: Mitochondrial Transfer Between Neurons and Glia

1. P2X7 Receptor-ATP "Find-Me" Signal Cascade for Mitochondrial Transfer Priming

Mechanism: Elevated extracellular ATP released from injured neurons activates P2X7 receptors on astrocytes, triggering calcium influx and PKCα-mediated phosphorylation of TRIM46 (Tripartite Motif Protein 46). This phosphorylation promotes F-actin polymerization and TNT formation, upregulating mitochondrial transfer capacity. Simultaneously, P2X7 activation induces mitochondrial translocation to the astrocytic plasma membrane

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation: Mitochondrial Transfer Hypotheses

Hypothesis 1: P2X7 Receptor-ATP "Find-Me" Signal Cascade

Strongest Specific Weakness

The TRIM46-PKCα-P2X7 axis lacks direct mechanistic support. You invoke TRIM46 phosphorylation by PKCα downstream of P2X7 activation as the trigger for F-actin polymerization and TNT formation. However, TRIM46's established function is in neuronal microtubule organization—specifically, regulating Golgi apparatus positioning and axon initial segment formation (van Beuningen et al., 2015, PMID: 25883316). There is no published evide

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Domain Expert Assessment: Mitochondrial Transfer Hypotheses in Alzheimer's Disease

1. Translational Potential: Top 2–3 Hypotheses

| Rank | Hypothesis | Translational Potential | Rationale |
|------|------------|------------------------|-----------|
| 1 | P2X7 Receptor-ATP Cascade (mechanistic framework) | High | P2X7 antagonists already in clinical pipelines for other indications; mechanism addresses neuroinflammation, a core AD feature; testable with existing tools |
| 2 | EV-Mediated Mitochondrial Delivery | Moderate-High | EV therapeutics are actively advancing

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

No price history recorded yet

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (5)

No extracted figures yet
CD38 in Neurodegeneration and Neuroinflammation.
Cells (2020) · PMID:32085567
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
32.3th percentile (776 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
5

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.050

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

KG Entities (20)

APPBNIP3BNIP3LCSF1RChR2GJA1LAMP2BMFN2P62PANX1PARKINRAB27ARAB27A/LAMP2BRHOT1SQSTM1Synthetic fusion proteinsh-495454efh-826df660h-d78123d1neurodegeneration

Related Hypotheses

CD38 Inhibition for NAD+ Restoration and Microglial Senescence Prevention
Score: 0.575 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (62 edges)

associated with (8)

RHOT1neurodegenerationBNIP3neurodegenerationBNIP3LneurodegenerationPANX1neurodegenerationRAB27A/LAMP2Bneurodegeneration
▸ Show 3 more

co associated with (10)

ChR2RHOT1ChR2RAB27A/LAMP2BGJA1Synthetic fusion proteinsChR2GJA1GJA1RHOT1
▸ Show 5 more

co discussed (39)

ChR2BNIP3LChR2RHOT1ChR2PANX1ChR2RAB27AChR2BNIP3
▸ Show 34 more

interacts with (2)

RAB27ALAMP2BLAMP2BRAB27A

targets (3)

h-826df660ChR2h-495454efSynthetic fusion proteinsh-d78123d1RAB27A/LAMP2B

Mechanism Pathway for CD38

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    RHOT1["RHOT1"] -->|associated with| neurodegeneration["neurodegeneration"]
    BNIP3["BNIP3"] -->|associated with| neurodegeneration_1["neurodegeneration"]
    BNIP3L["BNIP3L"] -->|associated with| neurodegeneration_2["neurodegeneration"]
    h_826df660["h-826df660"] -->|targets| ChR2["ChR2"]
    h_495454ef["h-495454ef"] -->|targets| Synthetic_fusion_proteins["Synthetic fusion proteins"]
    h_d78123d1["h-d78123d1"] -->|targets| RAB27A_LAMP2B["RAB27A/LAMP2B"]
    PANX1["PANX1"] -->|associated with| neurodegeneration_3["neurodegeneration"]
    ChR2_4["ChR2"] -->|associated with| neurodegeneration_5["neurodegeneration"]
    RAB27A["RAB27A"] -->|interacts with| LAMP2B["LAMP2B"]
    LAMP2B_6["LAMP2B"] -->|associated with| neurodegeneration_7["neurodegeneration"]
    LAMP2B_8["LAMP2B"] -->|interacts with| RAB27A_9["RAB27A"]
    ChR2_10["ChR2"] -->|co discussed| BNIP3L_11["BNIP3L"]
    style RHOT1 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration fill:#ef5350,stroke:#333,color:#000
    style BNIP3 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration_1 fill:#ef5350,stroke:#333,color:#000
    style BNIP3L fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration_2 fill:#ef5350,stroke:#333,color:#000
    style h_826df660 fill:#4fc3f7,stroke:#333,color:#000
    style ChR2 fill:#ce93d8,stroke:#333,color:#000
    style h_495454ef fill:#4fc3f7,stroke:#333,color:#000
    style Synthetic_fusion_proteins fill:#ce93d8,stroke:#333,color:#000
    style h_d78123d1 fill:#4fc3f7,stroke:#333,color:#000
    style RAB27A_LAMP2B fill:#ce93d8,stroke:#333,color:#000
    style PANX1 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration_3 fill:#ef5350,stroke:#333,color:#000
    style ChR2_4 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration_5 fill:#ef5350,stroke:#333,color:#000
    style RAB27A fill:#ce93d8,stroke:#333,color:#000
    style LAMP2B fill:#ce93d8,stroke:#333,color:#000
    style LAMP2B_6 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration_7 fill:#ef5350,stroke:#333,color:#000
    style LAMP2B_8 fill:#ce93d8,stroke:#333,color:#000
    style RAB27A_9 fill:#ce93d8,stroke:#333,color:#000
    style ChR2_10 fill:#ce93d8,stroke:#333,color:#000
    style BNIP3L_11 fill:#ce93d8,stroke:#333,color:#000

3D Protein Structure

🧬 CD38 — PDB 1YH3 Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

Mitochondrial transfer between neurons and glia

neurodegeneration | 2026-04-01 | completed

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)